HealthDay (10/18, Thompson) reports, “Up to 15 states now can apply for $1 million grants to help plan new Certified Community Behavioral Health Clinics (CCBHC) in their region, the U.S. Department of Health and Human Services (HHS) announced” on Oct. 18. Monies for the grants were “included in the Bipartisan Safer Communities Act, passed earlier this year.” What’s more, “the $15 million in…planning funds is in addition to nearly $300 million awarded in September for new and existing CCBHCs, the agency said.”

Related Links:

— “Feds Make Big Funding Push for More Mental Health Clinics ” Dennis Thompson, HealthDay, October 18, 2022

Healio (10/18, Downey) reports, “The COVID-19 pandemic and H1N1 epidemic were associated with adverse mental health events in adolescents and youth from low- and middle-income countries, researchers” concluded in a study that “used six databases to assess the mental health outcomes of adolescents and youth aged 10 to 24 years associated with four major pandemic outbreaks from January 2009 to January 2021 in low- and middle-income countries.” The findings of the 57-study systematic scoping review were published online Oct. 12 in JAMA Psychiatry.

Related Links:

— “Disease outbreaks linked to adverse mental health issues in adolescents, young people “Ken Downey Jr., Healio, October 18, 2022

Healio (10/17, Monostra) reports, “Adolescents with subclinical hypothyroidism do not have an increased risk for major depressive disorder [MDD] compared with those with normal thyroid function,” investigators concluded in a 4,118-adolescent study, the findings of which were published online Sept. 12 in the journal Thyroid.

Related Links:

— “No link between subclinical hypothyroidism, major depressive disorder among adolescents “Michael Monostra, Healio, October 17, 2022

HealthDay (10/17) reports, “A diagnosis of attention-deficit/hyperactivity disorder” (AD/HD) “does not appear to lower overall self-reported quality of life (QOL) among adolescents,” investigators concluded in a study that “compared QOL in 393 matched adolescents with and without” a diagnosis of AD/HD. The findings were published online Oct. 13 in JAMA Network Open.

Related Links:

— “Teens With ADHD Do Not Report Worse Quality of Life, HealthDay, October 17, 2022

Healio (10/17, Herpen) reports, “Nonadherence to treatment with buprenorphine is associated with an increased risk of opioid overdose as well as increased spending for healthcare among Medicare participants,” researchers concluded in a study that included “a total of 34,505 U.S. Medicare fee-for-service beneficiaries…diagnosed with opioid use disorder who received at least one two-week period of continuous buprenorphine treatment between 2010 and 2017.” The findings were published online Oct. 5 in JAMA Psychiatry.

Related Links:

— “Buprenorphine treatment gaps linked to increased overdose risk, higher care spending “Robert Herpen, Healio, October 17, 2022